Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3914107 | 0.82 | ALDH1A1 (0.51) | POLBALDH1A1GAAMAPTTSHR | |
| SCHEMBL3917694 | 0.78 | TSHR (0.55) | ALDH1A1TSHRLMNAHTTKMT2A | |
| SCHEMBL3919293 | 0.78 | TSHR (0.47) | POLBALDH1A1MAPTTSHRLMNA | |
| SCHEMBL6948417 | 0.77 | ALDH1A1 (0.81) | POLBALDH1A1GAALMNAL3MBTL1 | |
| SCHEMBL2839822 | 0.77 | MEN1 (0.75) | POLBLMNAHTTKMT2AMEN1 | |
| SCHEMBL3924077 | 0.77 | HSD11B1 (0.63) | POLBALDH1A1MAPTTSHRLMNA | |
| SCHEMBL3917525 | 0.75 | TSHR (0.53) | ALDH1A1TSHRLMNAHTTKMT2A | |
| SCHEMBL4541451 | 0.75 | TSHR (0.52) | ALDH1A1TSHRLMNAHTTKMT2A | |
| SCHEMBL3917555 | 0.75 | POLB (0.53) | POLBALDH1A1GAAMAPTTSHR | |
| SCHEMBL31315858 | 0.75 | ALDH1A1 (0.65) | POLBALDH1A1TSHRLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2035372-A1 | MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008005338-A1 | MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2008-01-10 | — | — | WO | disclosed |